KMT2A and leukemia: In the syngeneic murine AML model, Setd1b sgRNA expression decreased MLL-r leukemia cell propagation in vivo, even without FLT3-ITD or NrasG12D expression; thus, SETD1B requirement increased in the in vivo environment (Fig. 1G).